Novartis agrees to acquire Anthos for up to $3.1 billion
(Reuters) - Swiss pharmaceutical giant Novartis has agreed to acquire Anthos Therapeutics, a biopharma firm majority-owned by Blackstone's drug development unit, for up to $3.1 billion, the companies said on Tuesday.
Anthos was founded by the private equity firm's Blackstone Life Sciences business and by Novartis in 2019 to develop, manufacture, and commercialise abelacimab, a treatment to prevent strokes and the recurrence of blood clots.
The transaction, expected to close in the first half of this year, will cost Novartis $925 million upfront with potential additional payments of up to $2.15 billion, the company said.
"With its deep roots in the cardiovascular space, Novartis is especially well positioned to advance abelacimab's clinical development and bring this innovative product to healthcare providers and patients," Bill Meury, CEO at Anthos, said.
A Blackstone spokesperson said the deal was the largest sale to date of a majority-owned Blackstone Life Sciences company.
Anthos is conducting several phase 3 clinical studies, with data from these trials expected in the second half of 2026, Blackstone said.
Reuters reported in December 2023 that Blackstone was exploring the sale of Anthos.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wall Street Journal
42 minutes ago
- Wall Street Journal
The Future Ain't What It Used to Be for These Funds
With their words, the managers of private assets are telling investors that the best is yet to come. With their actions, they're suggesting the glory days already may be ending. Giant firms like Apollo, BlackRock, Blackstone, Capital Group, KKR, State Street and Vanguard Group are all rushing to get individual investors to buy 'alternatives,' including hedge funds, venture capital, and nontraded debt, equity and real estate.
UPI
44 minutes ago
- UPI
Swiss government proposes requiring banks to hold more capital
Switzerland's Federal Council Friday submitted new capital requirements for mega-banks like UBS in the wake of the Credit Suisse crisis. It requires UBS to hold $26 billion more in core capital. The Swiss National Bank and financial regulator FINMA both backed the proposed capital requirement changes. Photo by Hugo Philpott/UPI | License Photo June 6 (UPI) -- Switzerland's Federal Council Friday submitted new capital requirements for mega-banks like UBS in the wake of the Credit Suisse crisis. It requires UBS to hold $26 billion more in core capital. The Swiss Federal Council said in a statement that a review of the Credit Suisse crisis showed reforms are needed to reduce risks for the state, taxpayers and the economy. "These include stricter capital requirements for systemically important banks with foreign subsidiaries, additional requirements on the recovery and resolution of systemically important banks, the introduction of a senior managers regime for banks and additional powers for the Swiss Financial Market Supervisory Authority (FINMA)," the Federal Council statement said. The council is proposing amendments to the Banking Act in the wake of the Credit Suisse crisis that led to the UBS/CS merger. The Swiss National Bank supported the proposed amendments. "The Swiss National Bank supports the amendments at legislative and ordinance level planned by the Federal Council in the areas of capital and liquidity requirements for systemically important banks, early intervention, and recovery and resolution planning. The measures planned are key to strengthening banks' resilience and their resolvability in a crisis, and thus the stability of the financial system." "The crisis at Credit Suisse highlighted weaknesses in the regulatory framework. The regulatory adjustments now planned constitute a package of measures drawing the right lessons from this crisis." One major concern about UBS is its ability to cope with losses in its foreign units, and that's one of the reasons the Swiss government is increasing capital requirements. FINMA said it also backs the proposed changes ot the Banking Act. "FINMA welcomes the planned introduction of several preventive and disciplinary instruments that will set the right incentives for supervised institutions and thus make a decisive contribution to reducing the likelihood of crises and resolution occurring in the Swiss banking centre." FINMA said in particular, it supports, "the planned new statutory powers for FINMA in the areas of corporate governance, early intervention, recovery and resolution, as well as the introduction of higher capital requirements for systemically important banks with subsidiaries abroad." Morningstar senior equity analyst Johann Scholtz said in a note, "While winding down Credit Suisse's legacy businesses should free up capital and reduce costs for UBS, much of these gains could be absorbed by stricter regulatory demands." The new capital rules would require UBS to fully capitalize its foreign branches and do fewer stock buybacks. UBS took over Credit Suisse in 2023, with the government underwriting $10 billion in UBS losses created by the takeover.
Yahoo
an hour ago
- Yahoo
Was Jim Cramer Right About Blackstone Inc. (BX)?
We recently published a list of . In this article, we are going to take a look at where Blackstone Inc. (NYSE:BX) stands against other stocks that Jim Cramer discusses. In that older segment, a caller voiced concern over Blackstone Inc. (NYSE:BX) after a few months of underwhelming stock performance. Cramer acknowledged the market weakness in the private equity sector at the time, but still believed Blackstone remained a high-quality long-term hold. He said: 'The stock does not act well… That said, I know that there's value there and I think you have to be willing to recognize that this stock could be down 10%, but the value continues. Jonathan Gray is doing a great job. They own a huge number of companies… they own a data center business that is just second to none frankly. So I say hold on to it but be prepared… we're in a rocky moment for private equity right now.' Cramer called it a long-term hold, and the stock rewarded him with a +16.61% gain. Blackstone Inc. (NYSE:BX) is one of the world's largest alternative investment firms, managing assets across private equity, real estate, credit, and hedge fund strategies. The firm recently announced the acquisition of a utility company and Cramer had this to say about it in late May: 'We know Blackstone has a lot of data centers. We know TXNM is in the area with a lot of data centers. I still think this is motivated by the need to have cheap power. Although remember, they are not a generator. A side view of a traditional bank branch, its polished glass entrance indicating a secure and reliable banking experience. Overall, BX ranks 9th on our list of stocks that Jim Cramer discusses. While we acknowledge the potential of BX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
